Arvinas (ARVN) Other financing activities (2019 - 2022)
Arvinas' (ARVN) quarterly Other financing activities came in at $500000.0 in Q4 2022, down 86.84% year-on-year from $3.8 million in Q4 2021, and down 58.33% quarter-over-quarter from $1.2 million in Q3 2022.
Arvinas (ARVN) Other financing activities (2019 - 2022) Analysis & Trends
Arvinas' Other financing activities history runs 4 years deep, the most recent figure standing at $500000.0 for Q4 2022.
- On a quarterly basis, Other financing activities fell 86.84% year-over-year to $500000.0 in Q4 2022; TTM through Dec 2022 was $4.7 million, a 74.73% decrease from a year earlier, with the FY2022 full-year figure at $4.7 million, down 74.73% from the prior year.
- Other financing activities eased to $500000.0 in Q4 2022 per ARVN's latest filing, from $1.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $6.7 million in Q3 2021 and bottomed at $399488.0 in Q2 2019.
- The 4-year median for Other financing activities is $1.4 million (2020), against an average of $2.3 million.
- Across the five-year window, Other financing activities surged 1060.57% in 2021 and plunged 86.84% in 2022, its largest moves.
- Year by year, Other financing activities stood at $1.0 million in 2019, then soared by 398.08% to $5.1 million in 2020, then slipped by 25.39% to $3.8 million in 2021, then plunged by 86.84% to $500000.0 in 2022.
- Per Business Quant, the three latest ARVN Other financing activities figures stand at $500000.0 (Q4 2022), $1.2 million (Q3 2022), and $500000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 500,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Sep 30, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |
| Mar 31, 2022 | 2.50 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 3.80 Mn |
| Dec 31, 2021 | 3.80 Mn |
| Sep 30, 2021 | 6.70 Mn |
| Sep 30, 2021 | 6.70 Mn |
| Jun 30, 2021 | 3.60 Mn |
| Jun 30, 2021 | 3.60 Mn |
| Mar 31, 2021 | 4.50 Mn |
| Mar 31, 2021 | 4.50 Mn |
| Dec 31, 2020 | 5.09 Mn |
| Dec 31, 2020 | 5.09 Mn |
| Sep 30, 2020 | 577,303.00 |
| Sep 30, 2020 | 577,303.00 |